Long-term differential modulation of genes encoding orexigenic and anorexigenic peptides by leptin delivered by rAAV vector in ob/ob mice - Relationship with body weight change

H. Dhillon, Y. L. Ge, R. M. Minter, V. Prima, L. L. Moldawer, N. Muzyczka, S. Zolotukhin, P. S. Kalra, S. P. Kalra

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

We investigated the long-term effects of physiological levels of leptin produced by gene therapy on body weight (BW) and expression of genes that encode orexigenic and anorexigenic peptides in the hypothalamus. Recombinant adeno-associated viral vector (rAAV), a non-pathogenic and non-immunogenic vector, encoding leptin (βOb) was generated and administered iv to ob/ob mice lacking endogenous leptin. Whereas the lowest dose of rAAV-βOb (6 x 109 particles) was ineffective, the middle dose (6 x 1010 particles) curbed BW gain without affecting food consumption for 75 days of observation. A ten-fold higher dose (6 x 1011 particles) resulted in increased blood leptin levels and suppressed both BW gain and food consumption throughout the duration of the experiment. rAAV-βOb doses that either curbed BW without affecting food consumption or evoked BW loss and reduced food intake, decreased the expression of genes encoding the orexigenic peptides, neuropeptide Y and agouti-related peptide in the ARC, and the two doses were equally effective. Concomitantly, the expression of genes encoding the anorexigenic peptide, α-melanocyte stimulating hormone and cocaine-and- amphetamine regulatory transcript, was augmented with the latter gene displaying a dose-dependant response. These results document the efficacy of delivering biologically active leptin for extended periods by an iv injection of rAAV-βOb and show that physiological leptin concentrations simultaneously exert a tonic inhibitory effect on orexigenic and a stimulatory effect on anorexigenic signaling in the hypothalamus. This intricate dynamic interplay induced by leptin regulates BW with or without an effect on food intake in leptin-deficient ob/ob mice. Further, these results suggest that gene therapy is an effective mode of delivery to the hypothalamus of those therapeutic proteins that cross the blood-brain barrier to ameliorate neuroendocrine disorders. (C) 2000 Elsevier Science B.V.

Original languageEnglish (US)
Pages (from-to)97-105
Number of pages9
JournalRegulatory Peptides
Volume92
Issue number1-3
DOIs
StatePublished - Aug 25 2000

Fingerprint

Body Weight Changes
Gene encoding
Leptin
Modulation
Body Weight
Genes
Hypothalamus
Gene therapy
Gene Expression
Food
Genetic Therapy
Weight Gain
Eating
Melanocyte-Stimulating Hormones
AIDS-Related Complex
Peptides
pyroglutamyl-histidyl-glycine
Neuropeptide Y
Amphetamine
Blood-Brain Barrier

Keywords

  • AgrP
  • Gene Therapy
  • Hypothalamus
  • Leptin
  • NPY
  • POMC

ASJC Scopus subject areas

  • Biochemistry
  • Physiology
  • Endocrinology
  • Clinical Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Long-term differential modulation of genes encoding orexigenic and anorexigenic peptides by leptin delivered by rAAV vector in ob/ob mice - Relationship with body weight change. / Dhillon, H.; Ge, Y. L.; Minter, R. M.; Prima, V.; Moldawer, L. L.; Muzyczka, N.; Zolotukhin, S.; Kalra, P. S.; Kalra, S. P.

In: Regulatory Peptides, Vol. 92, No. 1-3, 25.08.2000, p. 97-105.

Research output: Contribution to journalArticle

Dhillon, H. ; Ge, Y. L. ; Minter, R. M. ; Prima, V. ; Moldawer, L. L. ; Muzyczka, N. ; Zolotukhin, S. ; Kalra, P. S. ; Kalra, S. P. / Long-term differential modulation of genes encoding orexigenic and anorexigenic peptides by leptin delivered by rAAV vector in ob/ob mice - Relationship with body weight change. In: Regulatory Peptides. 2000 ; Vol. 92, No. 1-3. pp. 97-105.
@article{7b3da1083d0e4c2bbb0f081d2afb444b,
title = "Long-term differential modulation of genes encoding orexigenic and anorexigenic peptides by leptin delivered by rAAV vector in ob/ob mice - Relationship with body weight change",
abstract = "We investigated the long-term effects of physiological levels of leptin produced by gene therapy on body weight (BW) and expression of genes that encode orexigenic and anorexigenic peptides in the hypothalamus. Recombinant adeno-associated viral vector (rAAV), a non-pathogenic and non-immunogenic vector, encoding leptin (βOb) was generated and administered iv to ob/ob mice lacking endogenous leptin. Whereas the lowest dose of rAAV-βOb (6 x 109 particles) was ineffective, the middle dose (6 x 1010 particles) curbed BW gain without affecting food consumption for 75 days of observation. A ten-fold higher dose (6 x 1011 particles) resulted in increased blood leptin levels and suppressed both BW gain and food consumption throughout the duration of the experiment. rAAV-βOb doses that either curbed BW without affecting food consumption or evoked BW loss and reduced food intake, decreased the expression of genes encoding the orexigenic peptides, neuropeptide Y and agouti-related peptide in the ARC, and the two doses were equally effective. Concomitantly, the expression of genes encoding the anorexigenic peptide, α-melanocyte stimulating hormone and cocaine-and- amphetamine regulatory transcript, was augmented with the latter gene displaying a dose-dependant response. These results document the efficacy of delivering biologically active leptin for extended periods by an iv injection of rAAV-βOb and show that physiological leptin concentrations simultaneously exert a tonic inhibitory effect on orexigenic and a stimulatory effect on anorexigenic signaling in the hypothalamus. This intricate dynamic interplay induced by leptin regulates BW with or without an effect on food intake in leptin-deficient ob/ob mice. Further, these results suggest that gene therapy is an effective mode of delivery to the hypothalamus of those therapeutic proteins that cross the blood-brain barrier to ameliorate neuroendocrine disorders. (C) 2000 Elsevier Science B.V.",
keywords = "AgrP, Gene Therapy, Hypothalamus, Leptin, NPY, POMC",
author = "H. Dhillon and Ge, {Y. L.} and Minter, {R. M.} and V. Prima and Moldawer, {L. L.} and N. Muzyczka and S. Zolotukhin and Kalra, {P. S.} and Kalra, {S. P.}",
year = "2000",
month = "8",
day = "25",
doi = "10.1016/S0167-0115(00)00155-5",
language = "English (US)",
volume = "92",
pages = "97--105",
journal = "Regulatory Peptides",
issn = "0167-0115",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - Long-term differential modulation of genes encoding orexigenic and anorexigenic peptides by leptin delivered by rAAV vector in ob/ob mice - Relationship with body weight change

AU - Dhillon, H.

AU - Ge, Y. L.

AU - Minter, R. M.

AU - Prima, V.

AU - Moldawer, L. L.

AU - Muzyczka, N.

AU - Zolotukhin, S.

AU - Kalra, P. S.

AU - Kalra, S. P.

PY - 2000/8/25

Y1 - 2000/8/25

N2 - We investigated the long-term effects of physiological levels of leptin produced by gene therapy on body weight (BW) and expression of genes that encode orexigenic and anorexigenic peptides in the hypothalamus. Recombinant adeno-associated viral vector (rAAV), a non-pathogenic and non-immunogenic vector, encoding leptin (βOb) was generated and administered iv to ob/ob mice lacking endogenous leptin. Whereas the lowest dose of rAAV-βOb (6 x 109 particles) was ineffective, the middle dose (6 x 1010 particles) curbed BW gain without affecting food consumption for 75 days of observation. A ten-fold higher dose (6 x 1011 particles) resulted in increased blood leptin levels and suppressed both BW gain and food consumption throughout the duration of the experiment. rAAV-βOb doses that either curbed BW without affecting food consumption or evoked BW loss and reduced food intake, decreased the expression of genes encoding the orexigenic peptides, neuropeptide Y and agouti-related peptide in the ARC, and the two doses were equally effective. Concomitantly, the expression of genes encoding the anorexigenic peptide, α-melanocyte stimulating hormone and cocaine-and- amphetamine regulatory transcript, was augmented with the latter gene displaying a dose-dependant response. These results document the efficacy of delivering biologically active leptin for extended periods by an iv injection of rAAV-βOb and show that physiological leptin concentrations simultaneously exert a tonic inhibitory effect on orexigenic and a stimulatory effect on anorexigenic signaling in the hypothalamus. This intricate dynamic interplay induced by leptin regulates BW with or without an effect on food intake in leptin-deficient ob/ob mice. Further, these results suggest that gene therapy is an effective mode of delivery to the hypothalamus of those therapeutic proteins that cross the blood-brain barrier to ameliorate neuroendocrine disorders. (C) 2000 Elsevier Science B.V.

AB - We investigated the long-term effects of physiological levels of leptin produced by gene therapy on body weight (BW) and expression of genes that encode orexigenic and anorexigenic peptides in the hypothalamus. Recombinant adeno-associated viral vector (rAAV), a non-pathogenic and non-immunogenic vector, encoding leptin (βOb) was generated and administered iv to ob/ob mice lacking endogenous leptin. Whereas the lowest dose of rAAV-βOb (6 x 109 particles) was ineffective, the middle dose (6 x 1010 particles) curbed BW gain without affecting food consumption for 75 days of observation. A ten-fold higher dose (6 x 1011 particles) resulted in increased blood leptin levels and suppressed both BW gain and food consumption throughout the duration of the experiment. rAAV-βOb doses that either curbed BW without affecting food consumption or evoked BW loss and reduced food intake, decreased the expression of genes encoding the orexigenic peptides, neuropeptide Y and agouti-related peptide in the ARC, and the two doses were equally effective. Concomitantly, the expression of genes encoding the anorexigenic peptide, α-melanocyte stimulating hormone and cocaine-and- amphetamine regulatory transcript, was augmented with the latter gene displaying a dose-dependant response. These results document the efficacy of delivering biologically active leptin for extended periods by an iv injection of rAAV-βOb and show that physiological leptin concentrations simultaneously exert a tonic inhibitory effect on orexigenic and a stimulatory effect on anorexigenic signaling in the hypothalamus. This intricate dynamic interplay induced by leptin regulates BW with or without an effect on food intake in leptin-deficient ob/ob mice. Further, these results suggest that gene therapy is an effective mode of delivery to the hypothalamus of those therapeutic proteins that cross the blood-brain barrier to ameliorate neuroendocrine disorders. (C) 2000 Elsevier Science B.V.

KW - AgrP

KW - Gene Therapy

KW - Hypothalamus

KW - Leptin

KW - NPY

KW - POMC

UR - http://www.scopus.com/inward/record.url?scp=0034714042&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034714042&partnerID=8YFLogxK

U2 - 10.1016/S0167-0115(00)00155-5

DO - 10.1016/S0167-0115(00)00155-5

M3 - Article

C2 - 11024571

AN - SCOPUS:0034714042

VL - 92

SP - 97

EP - 105

JO - Regulatory Peptides

JF - Regulatory Peptides

SN - 0167-0115

IS - 1-3

ER -